Researchers have developed a new tool that could help clinicians diagnose the most common type of breast cancer more accurately and make better treatment decisions. The tool, called EMBeddER (EMBER), ...

Nia Haware and Marcia Pennant work jointly as Legacy Marketing Officers in our Development and Communications Office.

A new study has provided novel insights into the effects of radiation on the immune cells surrounding breast cancer tumours. The findings show that the relationship between these cells, known as the ...

An innovative study has uncovered two genes that promote the formation of prostate tumours. Both genes activate a signalling pathway that plays a part in the growth, division and death of cells and is ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

Abeera is a first-year PhD student working across Medicinal Chemistry 4 and the In-Silico Medicinal Chemistry team. Abeera's PhD project will use Grand Canonical Monte Carlo Simulations to investigate ...

Tal joined the Generations Study research team in 2025 with Professor Garcia-Closas. After professional experience in large-scale automated data pipeline creation and management, he received his MSc ...

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment. Trevor Graham is Professor of ...